That is why the current wave of fake Ozempic-style drugs now circulating in the U.S by unlicensed and often foreign companies ...

Tariff wars and macro woes have impacted investor sentiment, weighing on stocks across various sectors. However, healthcare ...

Eli Lilly alleges Willow falsely claims its products are safe, effective and superior to its FDA-approved tirzepatide medicines, sold under Lilly's brand names: Mounjaro, which treats diabetes, and ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Cinnamon butter is smooth, creamy, and sweet with just the right amount of spice. Spread it over warm biscuits, toast, or ...

According to a new Wallethub report, Florida ranks the number 1 due in part to its large variety of attractions, like ...

Plus, salon owners are seeing a massive drawdown in clients coming in for their regular scheduled appointments, citing ...

Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step closer to hitting the ...

The company has two GLP-1-approved drugs, Zepbound (for weight loss) and Mounjaro (for diabetes), and the potential billions ...

Eli Lilly's new pill shows impressive results, matching Ozempic in lowering weight and blood sugar levels for diabetes ...

We recently published a list of the 10 Innovative Healthcare Stocks to Watch in 2025. In this article, we are going to take a ...

Earth Day is an annual event first held in the United States on April 22, 1970, to demonstrate support for environmental ...